Physician profile
Seth I Darkey
NPI 1881809135
$883.61
in general payments reported to CMS, 2019-2025
10 companies · $43.22 in 2025
The $43.22 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $11.23 · 2021: $242 · 2022: $242 · 2023: $120 · 2024: $77.32 · 2025: $43.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $301.86 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $247.78 | 2019-2024 | Collagenase Santyl |
| Takeda Pharmaceuticals U.S.A., INC. | $72.18 | 2022-2024 | Gattex |
| Merck Sharp & Dohme LLC | $63.85 | 2021-2022 | |
| Organogenesis INC. | $62.11 | 2022-2025 | Cygnus Matrix |
| Janssen Biotech, INC. | $54.40 | 2021-2022 | |
| Tactile Systems Technology INC | $26.92 | 2023 | Entre Plus, Flexitouch Plus |
| Myovant Sciences INC. | $22.25 | 2022 | |
| Abbvie INC. | $21.03 | 2021 | |
| Bsn Medical INC | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Darkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.